Case number 1:18-cv-01032
Celgene Corporation v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (38) |
| Oct 11, 2018 | 7 | Patent/Trademark Report to Commissioner (1) |
| Oct 11, 2018 | 7 | Notice of Dismissal (1) |
| Oct 11, 2018 | 7 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,962,940 B2; 7,427,638 B2; 7,659,302 B2; 7,893,101 B2; 8,455,536 B2; 9,018,243 B2. (Attachments: # (1) Notice of Dismissal)(nms) |
| Oct 10, 2018 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [6]. (nms) |
| Oct 9, 2018 | 6 | Notice (Other) (1) Docket Text: NOTICE of Dismissal by Celgene Corporation (Blumenfeld, Jack) |
| Jul 18, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Amneal Pharmaceuticals LLC on 7/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jul 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,962,940 B2 ;7,427,638 B2 ;7,659,302 B2 ;7,893,101 B2 ;8,455,536 B2 ;9,018,243 B2. (jcs) |
| Jul 12, 2018 | 1 | Exhibit A-G (236) |
| Jul 12, 2018 | 1 | Civil Cover Sheet (3) |
| Jul 12, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jul 12, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about 6/1/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/21/2021. (jcs) |
| Jul 12, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Celgene Corporation. (jcs) |
| Jul 12, 2018 | 1 | Main Document (38) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Amneal Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2418596.) - filed by Celgene Corporation. (Attachments: # (1) Exhibit A-G, # (2) Civil Cover Sheet)(jcs) |
| Jul 12, 2018 | 1 | Complaint* (1) |
